14 October 2025 - 17 October 2025
MA 02114 Boston, United States
5 Blossom Street
Wyndham Boston Beacon Hill
Pharma Partnering, Drug Safety & PPM Summit Boston
IN THE CHAIR
DAY 1
Anita Burrell - Principa, Anita Burrell Consulting LLC
DAY 2
Courtland (Corky) La Vallee - Biopharmaceutical Program Management Expert
DAY 3
Michael Myers - Associate Professor, Dept. of Clinical Pharmacology, Indiana University School of Medicine
OUR SPEAKERS AND PANELISTS
Dr. Richard M. Bayney
President & Founder, Project & Portfolio Value Creation
Emily Anderson
Client Engagement Partner – Global Life Sciences Lead, Turnberry Solutions
Saleha Amin
Senior Staff Program Manager, Insulet Corporation
Tania Bojanowski
I&I & DCVM Project Management Development Head, Sanofi
Kathi Breen
Director, Pipeline Program Management - Early Development, GSK
Christopher Buder
Vice President, Portfolio Strategy, Cardinal Health
Jacob Cancelliere
Vice President of Account Enablement, Rego Consulting
Amy Cartaya
Director, Global R&D Program Management, Alexion Pharmaceuticals
Monika Campbell
Director, IT Project & Portfolio Management, Karl Storz
Michael Cooperman
Global Head of Program Management, ZS Associates
Andrea Chen
Executive Director, Head of Program Management, Cour Pharmaceuticals Development
Stephen Cho
Founder and President, SSC Strategic Advisors LLC.
Rishi Dixit
Vice President, Strategic Solutions and Innovation, Atlas
Nathan Drabek
Director of Portfolio & Process Excellence, Bio-Rad Laboratories
Stuart Fort
Senior Director, PPM Operations & Business Planning, Eli Lilly
Robert Happy
Managing Director, Life Sciences, OnePlan Solutions
Ranjani Hild
Head, Global Program Management, Oncology, Novartis
Ananya Jain
Research, Portfolio Management Lead, Biogen
Brandie Jonas
Executive Director, Program and Project Management, Geron Corporation
Yashvika Khurana
Product & Solutions Lead, Atlas
Lance Knight
Chief Value Stream Architect, Broadcom
Chris Knight
Director, Program Management, Formation Bio
Aadithya Krishnan
Vice President, Corporate Development & Strategy Nested Therapeutics
Ivan Kugener
Vice President, Head of Global Portfolio Management, Valuation & Analytics, EMD Serono
Christian Lease
Director R&D Project Management Office, Takeda
Tyler McKenney
Senior Partner, Emendo Consulting Group
Biren Mistry
Director, Strategic Program Management, BMS
Carrie Nauyalis
Executive in Residence, Planview
Amy Noe
Principal Consultant, Latham Biopharma Group, part of SIA Partners
James Pavlovich
Vice President Customer Experience and Operations, Straumann Group
Kathryn Pellerin
Senior Project Manager, Biogen
Emma Price
Global Product Strategist Broadcom
Kristin Robbins
Vice President, Program & Portfolio Management, Normunity
Kelvin Roddy
Senior Director, Global Program & Portfolio Management, Alexion Pharmaceuticals
Aimee Rodrigues
Vice President, Life Sciences PPM Practices, Planisware
Stephanie Rosenblum
Program Director, Bicycle Therapeutics
Darshan Shah
Executive Director, Global Program Management, Incyte
Anusha Sivaramakrishnan
Enterprise Project Management & Governance Professional
Aditi Soni
Vice President - Head of Program and Alliance Management, Kelonia Therapeutics
Vinod Nair
Director, Strategy & Program Management, Innovation Lab, Novartis
Mckinna Teske
Senior Consultant – Business Transformation, Turnberry Solutions
Mark Zhang
Senior Director, Head of Global Program Management Oncology II, EMD Serono
Samir Vattompadam
Senior Vice President, Global Program Leadership, Kura Oncology
Deepak Veeraraghavan
Partner, Blue Matter
Tarun Walia
Senior Director & Head, Decision Science, Novo Nordisk
Erin Williams
Global Program Manager, EMD Serono
Wei Sylvia Zheng
Executive Director, Strategy & Program Management, MediLink Therapeutics
Philip M. Zack, DVM, PhD
Executive Life Sciences Advisor, OnePlan